Report Detail
Global Anti-depressant Drugs Market Insights, Forecast to 2025
- RnM2691878 |
- 31 May, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)
The global Anti-depressant Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-depressant Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Anti-depressant Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-depressant Drugs in these regions.
This research report categorizes the global Anti-depressant Drugs market by top players/brands, region, type and end user. This report also studies the global Anti-depressant Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ALKERMES PLC
ALLERGAN PLC
BRISTOL MYERS SQUIBB COMPANY
ELI LILLY AND COMPANY
GLAXOSMITHKLINE INC.
H. LUNDBECK A/S
MERCK INC.
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL INC.
Market size by Product
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others
Market size by End User
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti-depressant Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anti-depressant Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti-depressant Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anti-depressant Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Anti-depressant Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-depressant Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Anti-depressant Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Anti-depressant Drugs Market Size Growth Rate by Product
- 1.4.2 Tricyclic Antidepressants
- 1.4.3 Selective Serotonin Reuptake Inhibitors
- 1.4.4 Serotonin-Norepinephrine Reuptake Inhibitors
- 1.4.5 Monoamine Oxidase Inhibitors
- 1.4.6 Serotonin Antagonist
- 1.4.7 Reuptake Inhibitors
- 1.4.8 Others
- 1.5 Market by End User
- 1.5.1 Global Anti-depressant Drugs Market Size Growth Rate by End User
- 1.5.2 Major Depressive Disorder
- 1.5.3 Obsessive-Compulsive Disorder
- 1.5.4 Generalized Anxiety Disorder
- 1.5.5 Panic Disorder
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-depressant Drugs Market Size
- 2.1.1 Global Anti-depressant Drugs Revenue 2014-2025
- 2.1.2 Global Anti-depressant Drugs Sales 2014-2025
- 2.2 Anti-depressant Drugs Growth Rate by Regions
- 2.2.1 Global Anti-depressant Drugs Sales by Regions
- 2.2.2 Global Anti-depressant Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Anti-depressant Drugs Sales by Manufacturers
- 3.1.1 Anti-depressant Drugs Sales by Manufacturers
- 3.1.2 Anti-depressant Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Anti-depressant Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Anti-depressant Drugs Revenue by Manufacturers
- 3.2.1 Anti-depressant Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti-depressant Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Anti-depressant Drugs Price by Manufacturers
- 3.4 Anti-depressant Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-depressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-depressant Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-depressant Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Anti-depressant Drugs Sales by Product
- 4.2 Global Anti-depressant Drugs Revenue by Product
- 4.3 Anti-depressant Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Anti-depressant Drugs Breakdown Data by End User
6 North America
- 6.1 North America Anti-depressant Drugs by Countries
- 6.1.1 North America Anti-depressant Drugs Sales by Countries
- 6.1.2 North America Anti-depressant Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Anti-depressant Drugs by Product
- 6.3 North America Anti-depressant Drugs by End User
7 Europe
- 7.1 Europe Anti-depressant Drugs by Countries
- 7.1.1 Europe Anti-depressant Drugs Sales by Countries
- 7.1.2 Europe Anti-depressant Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-depressant Drugs by Product
- 7.3 Europe Anti-depressant Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Anti-depressant Drugs by Countries
- 8.1.1 Asia Pacific Anti-depressant Drugs Sales by Countries
- 8.1.2 Asia Pacific Anti-depressant Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Anti-depressant Drugs by Product
- 8.3 Asia Pacific Anti-depressant Drugs by End User
9 Central & South America
- 9.1 Central & South America Anti-depressant Drugs by Countries
- 9.1.1 Central & South America Anti-depressant Drugs Sales by Countries
- 9.1.2 Central & South America Anti-depressant Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Anti-depressant Drugs by Product
- 9.3 Central & South America Anti-depressant Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-depressant Drugs by Countries
- 10.1.1 Middle East and Africa Anti-depressant Drugs Sales by Countries
- 10.1.2 Middle East and Africa Anti-depressant Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Anti-depressant Drugs by Product
- 10.3 Middle East and Africa Anti-depressant Drugs by End User
11 Company Profiles
- 11.1 ALKERMES PLC
- 11.1.1 ALKERMES PLC Company Details
- 11.1.2 Company Business Overview
- 11.1.3 ALKERMES PLC Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 ALKERMES PLC Anti-depressant Drugs Products Offered
- 11.1.5 ALKERMES PLC Recent Development
- 11.2 ALLERGAN PLC
- 11.2.1 ALLERGAN PLC Company Details
- 11.2.2 Company Business Overview
- 11.2.3 ALLERGAN PLC Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 ALLERGAN PLC Anti-depressant Drugs Products Offered
- 11.2.5 ALLERGAN PLC Recent Development
- 11.3 BRISTOL MYERS SQUIBB COMPANY
- 11.3.1 BRISTOL MYERS SQUIBB COMPANY Company Details
- 11.3.2 Company Business Overview
- 11.3.3 BRISTOL MYERS SQUIBB COMPANY Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 BRISTOL MYERS SQUIBB COMPANY Anti-depressant Drugs Products Offered
- 11.3.5 BRISTOL MYERS SQUIBB COMPANY Recent Development
- 11.4 ELI LILLY AND COMPANY
- 11.4.1 ELI LILLY AND COMPANY Company Details
- 11.4.2 Company Business Overview
- 11.4.3 ELI LILLY AND COMPANY Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 ELI LILLY AND COMPANY Anti-depressant Drugs Products Offered
- 11.4.5 ELI LILLY AND COMPANY Recent Development
- 11.5 GLAXOSMITHKLINE INC.
- 11.5.1 GLAXOSMITHKLINE INC. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 GLAXOSMITHKLINE INC. Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 GLAXOSMITHKLINE INC. Anti-depressant Drugs Products Offered
- 11.5.5 GLAXOSMITHKLINE INC. Recent Development
- 11.6 H. LUNDBECK A/S
- 11.6.1 H. LUNDBECK A/S Company Details
- 11.6.2 Company Business Overview
- 11.6.3 H. LUNDBECK A/S Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 H. LUNDBECK A/S Anti-depressant Drugs Products Offered
- 11.6.5 H. LUNDBECK A/S Recent Development
- 11.7 MERCK INC.
- 11.7.1 MERCK INC. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 MERCK INC. Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 MERCK INC. Anti-depressant Drugs Products Offered
- 11.7.5 MERCK INC. Recent Development
- 11.8 PFIZER INC.
- 11.8.1 PFIZER INC. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 PFIZER INC. Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 PFIZER INC. Anti-depressant Drugs Products Offered
- 11.8.5 PFIZER INC. Recent Development
- 11.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
- 11.9.1 TEVA PHARMACEUTICAL INDUSTRIES LTD. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 TEVA PHARMACEUTICAL INDUSTRIES LTD. Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 TEVA PHARMACEUTICAL INDUSTRIES LTD. Anti-depressant Drugs Products Offered
- 11.9.5 TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent Development
- 11.10 TAKEDA PHARMACEUTICAL INC.
- 11.10.1 TAKEDA PHARMACEUTICAL INC. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 TAKEDA PHARMACEUTICAL INC. Anti-depressant Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 TAKEDA PHARMACEUTICAL INC. Anti-depressant Drugs Products Offered
- 11.10.5 TAKEDA PHARMACEUTICAL INC. Recent Development
12 Future Forecast
- 12.1 Anti-depressant Drugs Market Forecast by Regions
- 12.1.1 Global Anti-depressant Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Anti-depressant Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Anti-depressant Drugs Market Forecast by Product
- 12.2.1 Global Anti-depressant Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Anti-depressant Drugs Revenue Forecast by Product 2019-2025
- 12.3 Anti-depressant Drugs Market Forecast by End User
- 12.4 North America Anti-depressant Drugs Forecast
- 12.5 Europe Anti-depressant Drugs Forecast
- 12.6 Asia Pacific Anti-depressant Drugs Forecast
- 12.7 Central & South America Anti-depressant Drugs Forecast
- 12.8 Middle East and Africa Anti-depressant Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-depressant Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-depressant Drugs . Industry analysis & Market Report on Anti-depressant Drugs is a syndicated market report, published as Global Anti-depressant Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Anti-depressant Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
